NCBI PubMed Central
open access
Preventing physical and chemical degradation of the LABL-Fc-MOG(R5), a bifunctional peptide inhibitor, with formulation development approaches.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Nanotherapeutic Strategies for MASLD: From Pathological Mechanisms to Targeted Delivery Systems.#666147
- 21 CFR Part 514 — New Animal Drug Applications#506850
- Tailoring the morphology and crystallinity of MoS 2 for bacterial inhibition of Gram-negative and Gram-positive bacteria#666011
- YK-4-250, A Synthetic Telmisartan-Tempol Conjugate: Crystal Structure of a Stabilized Free Radical Containing An Angiotensin AT₁ Receptor Inhibitor#1001621
- Targeted Protein Degradation#274049
Record · ID 330839
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive